Last Updated: 06/11/2023
Prototype formulation optimization of Hydroxychloroquine sulfate with an interwoven taste-masking system to facilitate pediatric administration
Objectives
This project will develop a liquid formulation of hydroxychloroquine sulfate, a drug currently approved for the treatment of lupus, rheumatoid arthritis, and malaria.
Principal Institution
Principal Investigators / Focal Persons
External reference
Thematic Categories
Date
Jun 2020
Total Project Funding
$110,000
Funding Details
North Carolina Biotechnology Center (NCBiotech), United States
Grant ID: NC476024d
Project Site
Related Resources
